Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
COVID-19: breaking down a global health crisis
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …
century, with over one-hundred million infections and over two million deaths to date. It is a …
Risk factors for severe and critically ill COVID‐19 patients: a review
Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …
The impact of COVID-19 disease on platelets and coagulation
GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …
patients develop a severe proinflammatory state which can be associated with a unique …
Predictors of COVID‐19 severity: a literature review
B Gallo Marin, G Aghagoli, K Lavine… - Reviews in medical …, 2021 - Wiley Online Library
Summary The coronavirus disease 2019 (COVID‐19) pandemic is a rapidly evolving global
emergency that continues to strain healthcare systems. Emerging research describes a …
emergency that continues to strain healthcare systems. Emerging research describes a …
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
M Apicella, MC Campopiano, M Mantuano… - The lancet Diabetes & …, 2020 - thelancet.com
Since the initial COVID-19 outbreak in China, much attention has focused on people with
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …
diabetes because of poor prognosis in those with the infection. Initial reports were mainly on …
COVID-19: from an acute to chronic disease? Potential long-term health consequences
V Higgins, D Sohaei, EP Diamandis… - Critical reviews in …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
In 2019–2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent
of a several acute respiratory infection named COVID-19, which is causing a worldwide …
of a several acute respiratory infection named COVID-19, which is causing a worldwide …
Biomarkers associated with COVID-19 disease progression
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …